1![FOR IMMEDIATE RELEASE The Gores Group Completes Sale of Therakos Leading Immunotherapy Company Achieved Significant Growth Following Carve-out from Former Division of Johnson & Johnson LOS ANGELES, CA, September 28, 2015 FOR IMMEDIATE RELEASE The Gores Group Completes Sale of Therakos Leading Immunotherapy Company Achieved Significant Growth Following Carve-out from Former Division of Johnson & Johnson LOS ANGELES, CA, September 28, 2015](https://www.pdfsearch.io/img/a7ba79da63ebb1686de1871e8327b225.jpg) | Add to Reading ListSource URL: www.gores.comLanguage: English - Date: 2015-09-28 03:05:27
|
---|
2![Important Safety Information (ISI) – Patient Version (Extended) INDICATIONS Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopher Important Safety Information (ISI) – Patient Version (Extended) INDICATIONS Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopher](https://www.pdfsearch.io/img/523b8f07f223ee0b2ca9124de06188d2.jpg) | Add to Reading ListSource URL: www.therakos.comLanguage: English - Date: 2012-03-15 08:05:52
|
---|
3![1460544C_US[removed]Manufactured by DSM Pharmaceuticals, Inc., Greenville, NC[removed]For Therakos, Inc., 10 North High Street, Suite 300, West Chester, PA[removed]USA 1460544C_US[removed]Manufactured by DSM Pharmaceuticals, Inc., Greenville, NC[removed]For Therakos, Inc., 10 North High Street, Suite 300, West Chester, PA[removed]USA](https://www.pdfsearch.io/img/7e71fcd7315eac2821cd9f87476619a8.jpg) | Add to Reading ListSource URL: www.therakos.comLanguage: English - Date: 2014-04-01 08:04:32
|
---|
4![DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services News Flash – In response to shortage of liposomal doxorubicin (Doxil), the Food and Drug Administration is permitting the temporary impor DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services News Flash – In response to shortage of liposomal doxorubicin (Doxil), the Food and Drug Administration is permitting the temporary impor](https://www.pdfsearch.io/img/8321e8547d864361293dbd82b0bb1769.jpg) | Add to Reading ListSource URL: www.cms.govLanguage: English - Date: 2012-09-25 15:11:20
|
---|
5![CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare Claims Processing CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare Claims Processing](https://www.pdfsearch.io/img/3ce71eeb2372354937902b25143ace45.jpg) | Add to Reading ListSource URL: www.cms.govLanguage: English - Date: 2013-11-22 12:46:28
|
---|
6![CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare National Coverage CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare National Coverage](https://www.pdfsearch.io/img/e4de8feca89161796f3d5531cf22a0a9.jpg) | Add to Reading ListSource URL: www.cms.govLanguage: English - Date: 2013-11-22 12:47:07
|
---|
7![On April 30, 2012, CMS issued a national coverage determination (NCD) to allow coverage of extracorporeal photopheresis (ECP) for the treatment of bronchiolitis obliterans syndrome (BOS) following lung allograft transpla On April 30, 2012, CMS issued a national coverage determination (NCD) to allow coverage of extracorporeal photopheresis (ECP) for the treatment of bronchiolitis obliterans syndrome (BOS) following lung allograft transpla](https://www.pdfsearch.io/img/718e5bc6f18d641902f253d3b7979022.jpg) | Add to Reading ListSource URL: www.cms.govLanguage: English - Date: 2014-07-08 10:59:00
|
---|